Keyphrases
Prostaglandin E2
100%
Gene Expression
100%
Receptor-mediated
100%
Latency
100%
Kaposi's Sarcoma-associated Herpesvirus
100%
Expression Strategy
100%
HHV-8
100%
EP Receptors
100%
Piracy
100%
Latency-associated nuclear Antigen
66%
Cyclooxygenase-2
33%
Signaling Molecules
33%
Chronic Inflammation
33%
Ca2+
33%
Phosphoinositide 3-kinase (PI3K)
33%
NF-B
33%
Virus Latency
33%
Receptor Antagonist
16%
Prostaglandin E2 Receptor
16%
Inflammatory Response
16%
Novel Paradigm
16%
Latent Infection
16%
Promoter Activity
16%
Malignancy
16%
Latently Infected
16%
Receptor Agonist
16%
C-Jun
16%
Virus Genome
16%
MPGES-1
16%
293 Cells
16%
Survival Benefit
16%
OCT1
16%
Jun Transcription Factor
16%
Genome Plasticity
16%
Latent Genes
16%
Oct6
16%
Medicine and Dentistry
Gene Expression
100%
Pathogen
100%
Herpesviridae
100%
Prostaglandin E2
100%
Kaposi Sarcoma
100%
Receptor Mediated Signaling
100%
Receptor
71%
Latency Associated Nuclear Antigen
57%
Promoter Region
28%
Chronic Inflammation
28%
Calcium Ion
28%
Cyclooxygenase 2
28%
Virus Latency
28%
Latent Virus Infection
14%
Cancer
14%
Carcinogenesis
14%
Serositis
14%
Synthetase
14%
Receptor Antagonist
14%
Virus Genome
14%
Protein C Jun
14%
Pharmacology, Toxicology and Pharmaceutical Science
Infectious Agent
100%
Receptor
100%
Prostaglandin E2
100%
Herpesviridae
100%
Kaposi Sarcoma
100%
Latency Associated Nuclear Antigen
57%
Calcium Ion
28%
Chronic Inflammation
28%
Cyclooxygenase 2
28%
Synthetase
14%
Carcinogenesis
14%
Inflammation
14%
Receptor Antagonist
14%
Elimination
14%
Receptor Agonist
14%
Latent Virus Infection
14%
Protein C Jun
14%
Biochemistry, Genetics and Molecular Biology
Infectious Agent
100%
Gene Expression
100%
Herpesviridae
100%
Prostaglandin E2
100%
Promoter Region
28%
Cyclooxygenase
28%
Virus Latency
28%
Synthase
14%
Metabolite
14%
Virus Genome
14%
Carcinogenesis
14%
Receptor Antagonist
14%
Receptor Agonists
14%
Protein C Jun
14%
YY1
14%
EP1 Receptor
14%